Dudediligence.

Cytosorbents Corporation

CTSONASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$8.6MSep ’24$9.2MDec ’24$8.7MMar ’25$9.6MJun ’25$9.5MSep ’25$9.2MDec ’25$8.9MMar ’26$9.6MJun ’26
Net income, by quarter
−$2.8MSep ’24−$7.6MDec ’24−$1.5MMar ’25$1.9MJun ’25−$3.2MSep ’25−$5.5MDec ’25−$5.1MMar ’26−$4.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$43.2M$34.7M$31.1M$35.6M$37.1M
Gross profit$32.1M$20.7M$22.0M$24.9M$26.5M
Operating income−$22.7M−$31.5M−$31.9M−$16.5M−$14.7M
Net income−$24.6M−$32.8M−$29.2M−$20.7M−$8.2M
Operating cash flow−$14.0M−$28.2M−$21.7M−$14.4M−$12.4M
Free cash flow−$17.6M−$34.3M−$22.2M−$14.7M−$12.5M
Cash$52.1M$22.1M$14.1M$3.3M$6.2M
Debtnone on file$5.0M$5.0M$14.0M$16.7M
Shares outstanding43.6M43.6M54.2M54.8M62.8M